ArticlePloS one2019

Asparaginase combined with discontinuous dexamethasone improves antileukemic efficacy without increasing osteonecrosis in preclinical models.

Seth E Karol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.